Publication | Open Access

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

VaccinationCovid-19 PandemicVaccine TrialVirologyMolnupiravir Versus PlaceboEarly Sars-cov-2 InfectionVaccine EfficacyInfection ControlMedicineCovid-19Agile Cst-2